Skip to main content
Premium Trial:

Request an Annual Quote

People in the News: Daniel Grosu; Tim Hall

Premium

Illumina has named Daniel Grosu to the newly created position of vice president and chief medical officer. Grosu will "play a key role in building Illumina's diagnostic capabilities through collaborations with regulatory agencies, internal product development teams, and Illumina's CLIA-certified clinical laboratory," the firm said.

Prior to joining Illumina, Grosu was group director of clinical science and clinical and medical affairs at Ortho-Clinical Diagnostics. He was also previously the director and global clinical leader of global clinical development for Bayer Healthcare Pharmaceuticals' diagnostic imaging business. Before that, Grosu worked at Siemens Medical Solutions.

He earned a medical degree from Saint Louis University and an MBA from the University of Oxford.


Oxford Gene Technology has tapped Tim Hall to be its new finance director as of January 2012.

Hall most recently was finance director of Lombard Medical Technologies. He also was director of strategic planning at Medeva and chief financial officer at Celltech Pharmaceuticals.

Hall has a business administration degree from the University of Bath in the UK and qualified as an accountant with Touche Ross.

The Scan

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.

DNA Storage Method Taps Into Gene Editing Technology

With a dual-plasmid system informed by gene editing, researchers re-wrote DNA sequences in E. coli to store Charles Dickens prose over hundreds of generations, as they recount in Science Advances.

Researchers Model Microbiome Dynamics in Effort to Understand Chronic Human Conditions

Investigators demonstrate in PLOS Computational Biology a computational method for following microbiome dynamics in the absence of longitudinally collected samples.

New Study Highlights Role of Genetics in ADHD

Researchers report in Nature Genetics on differences in genetic architecture between ADHD affecting children versus ADHD that persists into adulthood or is diagnosed in adults.